1. Home
  2. ASTL vs VIR Comparison

ASTL vs VIR Comparison

Compare ASTL & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Algoma Steel Group Inc.

ASTL

Algoma Steel Group Inc.

HOLD

Current Price

$3.75

Market Cap

467.0M

Sector

Industrials

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.47

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTL
VIR
Founded
1902
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
467.0M
1.5B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
ASTL
VIR
Price
$3.75
$9.47
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$19.63
AVG Volume (30 Days)
1.2M
4.3M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
2.70%
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
N/A
$68,556,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$33.17
$925.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.02
$4.16
52 Week High
$7.25
$10.91

Technical Indicators

Market Signals
Indicator
ASTL
VIR
Relative Strength Index (RSI) 38.16 57.65
Support Level $3.54 $4.64
Resistance Level $4.67 $10.91
Average True Range (ATR) 0.28 0.61
MACD -0.12 -0.05
Stochastic Oscillator 26.06 49.69

Price Performance

Historical Comparison
ASTL
VIR

About ASTL Algoma Steel Group Inc.

Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: